Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
67 studies found for:    blood transfusion | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting Extended Dosing With Eltrombopag for Severe Aplastic Anemia
Condition: Severe Aplastic Anemia (SAA)
Intervention: Drug: Eltrombopag
22 Recruiting AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
Condition: Traumatic Shock
Intervention: Drug: Vasopressin
23 Recruiting Pilot Trial of Allogeneic Blood or Marrow Transplanation for Primary Immunodeficiencies
Conditions: Primary T-cell Immunodeficiency Disorders;   Common Variable Immunodeficiency;   Immune System Diseases;   Autoimmune Lymphoproliferative;   Lymphoproliferative Disorders
Interventions: Drug: Immunosuppression Only Conditioning;   Drug: Reduced Intensity Conditioning;   Drug: Myeloablative Conditioning;   Drug: GVHD Prophylaxis;   Procedure: Allo BMT
24 Recruiting Evaluation of Sickle Cell Liver Disease
Condition: Sickle Cell Disease
Intervention:
25 Recruiting BioRBC Survival in Adults With Prior Antibody Response to BioRBCs
Condition: Anemia
Intervention: Drug: biotin labelled RBCs
26 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
27 Recruiting TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma
Condition: Lymphoma
Interventions: Drug: Fludarabine Phosphate;   Drug: Mesna;   Drug: Cyclophosphamide;   Radiation: Total nodal irradiation;   Biological: T Cell-Depleted Hematopoietic Stem Cell Transplantation;   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Procedure: Peripheral Blood Stem Cell Transplantation;   Drug: Mycophenolate Mofetil;   Drug: Tacrolimus;   Biological: Rituximab
28 Not yet recruiting Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia
Conditions: Hematologic Malignancies;   Hypoproliferative Thrombocytopenia
Interventions: Device: Mirasol platelets (MIR PLTs);   Device: Reference platelets (REF PLTs)
29 Recruiting Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Conditions: Blood Donors;   Research Subjects;   Apheresis
Intervention:
30 Recruiting Blood Collection From Healthy Volunteers and Patients for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) Products
Condition: Induced Pluripotent Stem Cells
Intervention:
31 Recruiting Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS);   Severe Aplastic Anemia (SAA)
Interventions: Other: Umbilical Cord Blood;   Other: Haploidentical Stem Cells;   Device: Miltenvi CliniMACs CD34 Reagent System
32 Recruiting Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy
Condition: Healthy Volunteer
Intervention:
33 Recruiting Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)
Condition: Acute Myeloid Leukemia
Intervention:
34 Recruiting Natural History Study for BEN
Condition: Neutropenia
Intervention:
35 Recruiting Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products
Conditions: Bone Marrow;   Bone Marrow Stromal Cells;   Mesenchymal Stem Cells;   Blood Donors
Intervention:
36 Not yet recruiting Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission
Conditions: Adult Acute Myeloid Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission
Interventions: Drug: Cytarabine;   Other: Laboratory Biomarker Analysis;   Procedure: Peripheral Blood Stem Cell Transplantation;   Biological: Therapeutic Allogeneic Lymphocytes
37 Recruiting Australian and New Zealand Massive Transfusion Registry
Conditions: Massive Transfusion;   Trauma;   Cardiothoracic Surgery;   Gastrointestinal Bleeding;   Vascular Surgery;   Obstetric Bleeding;   Liver Transplant
Intervention:
38 Available Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.
Condition: Hematopoietic/Lymphoid Cancer
Intervention: Biological: Allogenic T cell-depleted hematopoietic stem cell transplantation
39 Recruiting Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates
Condition: Neonatal Thrombocytopenia
Intervention:
40 Recruiting American Trial Using Tranexamic Acid in Thrombocytopenia
Condition: Thrombocytopenia
Interventions: Drug: Tranexamic Acid;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.